4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001193125-26-377309
Chief Medical Officer sold 7,068 shares at an average $60.25 ($425,829)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
KENNEY CHRISTOPHER JOHN · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-28 | Sale : show line 1 in the form 10b5-1 | −6,368 | $60.17 | $383,145 | 702 | D |
| 2026-08-28 | Sale : show line 2 in the form 10b5-1 | −700 | $60.98 | $42,684 | 2 | D |
| Open-market sales · 7,068 sh · avg $60.25 · $425,829 | ||||||
Loading xslF345X06/ownership.xml…